About
Genematrix is developing new diagnostic products for various diseases by developing a globally competitive core platform technologies in the field of molecular diagnostics, which is attracting attention as a high-technology in the line of biotechnology. The Molecular Diagnostic market has high growth rates among in-vitro diagnostics markets and is a high value-added industry that is highly dependent on advanced countries since global companies prevailed the most core technologies. Genematrix, since the beginning of the company, has developed its own technologies that is globally competitive in the field of molecular diagnostics through joint research with domestic and international companies and research institutes.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 116 investors are based in Seongnam, Kyonggi-do, South Korea.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Seongnam, South Korea
Contact Information
Find more investors like GeneMatrix
Search Investors